Maze Therapeutics (MAZE) plunged ~37% on Wednesday despite reporting encouraging initial data from a Phase 2 trial for its lead asset, MZE829, targeted at broad APOL1-mediated kidney disease, a ...

The rise of vibe coding tools is changing how developers build software, turning ideas into working applications faster than ever. Instead of writing every line manually, developers can now describe ...

A Canadian who has worked in the gaming industry for over two decades, Beck grew up on games such as Final Fantasy and Super Mario Bros. He specalizes in roleplaying games, but covers titles in almost ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Vibe coding is transforming work by letting anyone describe and build software with AI, ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Dany Lepage discusses the architectural ...

AI coding agents are reshaping how developers write, debug, and maintain software in 2026. The debate around Claude Code vs ChatGPT Codex highlights two distinct philosophies: local-first reasoning ...

Hello, and welcome back to Fast Company’s Plugged In. “Programming, as it turns out, is just typing.” Talking at Cisco’s AI Summit in San Francisco on February 3, Nvidia CEO Jensen Huang made that ...

On Monday, OpenAI launched Codex, an agentic coding tool marketed to software developers. Today, OpenAI also launched a new model designed to turbo-charge Codex: GPT-5.3 Codex. The company says that ...

Artificial intelligence is entering the era of self-improvement. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive content. On Thursday afternoon, OpenAI ...

A screenshot of Xcode 26.3 showing the IDE's new Intelligence menu for picking coding agent. (Apple) Apple has just released Xcode 26.3, and it's a big step forward in terms of the company's support ...

Maze Therapeutics (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines for patients with kidney and metabolic diseases, visits the Nasdaq MarketSite ...

AI coding tools are rapidly changing how we produce software, and the industry is embracing it—perhaps at the expense of entry-level coding jobs. Generative AI’s ability to write software code has ...